Search Results - Yu Hara
- Showing 1 - 20 results of 26
- Go to Next Page
-
1
Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observationa... by Yusuke Saigusa, Takeshi Kaneko, Yu Hara, Nobuyuki Horita, Yoshihiro Hirai
Published in BMJ Open (2022-09-01)Get full text
Article -
2
-
3
-
4
-
5
Heme oxygenase-1 as an important predictor of the severity of COVID-19. by Yu Hara, Jun Tsukiji, Aya Yabe, Yoshika Onishi, Haruka Hirose, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko, Toshiaki Ebina
Published in PLoS ONE (2022-01-01)Get full text
Article -
6
Clinical Features and Risk Factors for Mortality in Hospitalized Older Adults with Pneumonia by Nobuhiko Fukuda, Nobuaki Kobayashi, Makoto Masuda, Aya Wakabayashi, Nobuko Kusano, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masanori Nishikawa, Takeshi Kaneko
Published in Canadian Respiratory Journal (2021-01-01)Get full text
Article -
7
The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis by Kazunori Nakamura, Yukio Fujita, Hao Chen, Kohei Somekawa, Fumihiro Kashizaki, Harumi Koizumi, Kenichi Takahashi, Nobuyuki Horita, Yu Hara, Shigeo Muro, Takeshi Kaneko
Published in Diseases (2023-10-01)Get full text
Article -
8
ZNF185 prevents stress fiber formation through the inhibition of RhoA in endothelial cells by Soichiro Suzuki, Fumiaki Ando, Sae Kitagawa, Yu Hara, Tamami Fujiki, Shintaro Mandai, Koichiro Susa, Takayasu Mori, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida
Published in Communications Biology (2023-01-01)Get full text
Article -
9
The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease by Yurika Nishikawa, Yu Hara, Yoichi Tagami, Ryo Nagasawa, Kota Murohashi, Ayako Aoki, Katsushi Tanaka, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Published in Canadian Respiratory Journal (2021-01-01)Get full text
Article -
10
Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan by Hiromi Matsumoto, Nobuaki Kobayashi, Satoru Shinoda, Atsushi Goto, Ayami Kaneko, Nobuhiko Fukuda, Chisato Kamimaki, Sousuke Kubo, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Yoshihiro Ishikawa, Takeshi Kaneko
Published in Scientific Reports (2023-03-01)Get full text
Article -
11
ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease by Hiroaki Fujii, Yu Hara, Yusuke Saigusa, Yoichi Tagami, Kota Murohashi, Ryo Nagasawa, Ayako Aoki, Ami Izawa, Kenichi Seki, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Takeshi Kaneko
Published in Canadian Respiratory Journal (2023-01-01)Get full text
Article -
12
The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study by Ayako Aoki, Yu Hara, Hiroaki Fujii, Kota Murohashi, Ryo Nagasawa, Yoichi Tagami, Tatsuji Enomoto, Yutaka Matsumoto, Makoto Masuda, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Makoto Kudo, Takashi Ogura, Takeshi Kaneko
Published in PLoS ONE (2023-01-01)Get full text
Article -
13
iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis by Takefumi Suzuki, Koichiro Susa, Hiroaki Kikuchi, Yuta Nakano, Tomoki Yanagi, Yu Hara, Tamami Fujiki, Fumiaki Ando, Shintaro Mandai, Yutaro Mori, Takayasu Mori, Hiroaki Iwasa, Yutaka Hata, Shinichi Uchida, Eisei Sohara
Published in Stem Cell Research & Therapy (2025-09-01)Get full text
Article -
14
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases by Momo Hirata, Yu Hara, Hiroaki Fujii, Kota Murohashi, Yusuke Saigusa, Shiqi Zhao, Miyu Kobayashi, Ryo Nagasawa, Yoichi Tagami, Ami Izawa, Yukiko Otsu, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Takeshi Kaneko
Published in BMC Pulmonary Medicine (2024-01-01)Get full text
Article -
15
The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study. by Ayako Aoki, Yu Hara, Hiroaki Fujii, Kota Murohashi, Ryo Nagasawa, Yoichi Tagami, Tatsuji Enomoto, Yutaka Matsumoto, Makoto Masuda, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Makoto Kudo, Takashi Ogura, Takeshi Kaneko
Published in PLoS ONE (2023-01-01)Get full text
Article -
16
MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer by Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, Chisato Kamimaki, Katsushi Tanaka, Sousuke Kubo, Kentaro Nakashima, Shuhei Teranishi, Saki Manabe, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masaki Yamamoto, Makoto Kudo, Hongmei Piao, Takeshi Kaneko
Published in Thoracic Cancer (2020-10-01)Get full text
Article -
17
Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases by Yoichi Tagami, Yu Hara, Kota Murohashi, Ryo Nagasawa, Yurika Nishikawa, Meiro Tanaka, Ayako Aoki, Katsushi Tanaka, Kentaro Nakashima, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Koji Okudela, Takeshi Kaneko
Published in Canadian Respiratory Journal (2021-01-01)Get full text
Article -
18
Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease by Yoichi Tagami, Yu Hara, Kota Murohashi, Ryo Nagasawa, Hiroaki Fujii, Ami Izawa, Aya Yabe, Yusuke Saigusa, Miyu Kobayashi, Masafumi Shiida, Momo Hirata, Yukiko Otsu, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Takeshi Kaneko
Published in Scientific Reports (2023-12-01)Get full text
Article -
19
Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study by Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, Sousuke Kubo, Katsushi Tanaka, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masanori Nishikawa, Kenji Miura, Harumi Koizumi, Yu Ito, Motofumi Tsubakihara, Naoki Miyazawa, Makoto Kudo, Masaharu Shinkai, Takeshi Kaneko
Published in BMC Cancer (2022-10-01)Get full text
Article -
20
Geographic and economic influences on benralizumab prescribing for severe asthma in Japan by Nobuaki Kobayashi, Hiromi Matsumoto, Kohei Somekawa, Ayami Kaneko, Nobuhiko Fukuda, Suguru Muraoka, Yukiko Ohtsu, Momo Hirata, Ryo Nagasawa, Sousuke Kubo, Kota Murohashi, Hiroaki Fujii, Ayako Aoki, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Takeshi Kaneko
Published in Scientific Reports (2024-07-01)Get full text
Article
